Skip to content

Telemedicine Education for Rural Children With Asthma

Telemedicine Education for Rural Children With Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00964301
Enrollment
106
Registered
2009-08-24
Start date
2009-08-31
Completion date
2015-03-31
Last updated
2017-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Low-income, Quality of life, Children

Brief summary

The investigators will implement an interactive school-based telemedicine education program for rural low-income, minority children with asthma, their caregivers, and school nurses in the Delta region of Arkansas. Specific aims: 1. The investigators will examine changes in asthma symptoms control and other health outcomes such as activity levels and family/child emotional health in the intervention group compared to a usual care group. 2. The investigators will examine changes in asthma knowledge, self-efficacy, and quality of life in the intervention participants and their caregivers compared to a usual care group.

Detailed description

The investigators will conduct a prospective study to examine the impact of an interactive, telemedicine asthma intervention among children living in the rural Delta region of Arkansas.

Interventions

Student Asthma Education. Each student will engage in 6 age-appropriate sessions on various aspects of asthma health. Caregiver Asthma Education. The primary caregiver will engage in 2 asthma education sessions. School Nurse Asthma Education. School nurses will participate in 2 sessions. Primary Care Provider (PCP) Communication. The PCP of the intervention group participant will be notified of his/her patient's baseline asthma assessment. They will receive updates summarizing each telemedicine intervention.

OTHERUsual care

Participants will receive asthma care by their PCP with no education sessions or PCP communications by the research staff.

Sponsors

University of Arkansas
CollaboratorOTHER
Arkansas Children's Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Study participants will be English-speaking children ages 7-17 years with physician-diagnosed asthma and/or active symptoms in the previous 12 months. * Active symptoms include one or more of the following: * experience daytime wheezing, shortness of breath, and/or coughing two or more times a week for the last 4 weeks; * nighttime wheezing, shortness of breath and/or cough more than once a week; * take asthma medication more than two days a week; * have been treated in a hospital or emergency department two or more times in the last two years for asthma symptoms; * have been treated in a hospital or emergency department two or more times in the last two years for asthma symptoms have episodes of asthma-like symptoms when playing/exercising. * Potentially eligible participants will be screened using an asthma screener to confirm eligibility.

Exclusion criteria

* Children with significant underlying respiratory disease other than asthma (such as cystic fibrosis) or significant co-morbid conditions (such as severe developmental delay or cerebral palsy) will be excluded from the study. * The primary caregiver and child will be asked questions via telephone interview about how asthma affects the child every day. Children with no telephone number or contact telephone number will be excluded.

Design outcomes

Primary

MeasureTime frame
The investigators will examine changes in asthma symptoms control and health outcomes in the intervention group compared to a usual care group.One year

Secondary

MeasureTime frame
The investigators will examine changes in asthma knowledge, self-efficacy, and quality of life of the intervention participants and their caregivers compared to a usual care group.One year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026